Fertility preservation in boys: Spermatogonial stem cell transplantation and testicular grafting

被引:4
|
作者
Goossens, E. [1 ]
Tournaye, H. [1 ,2 ]
机构
[1] Vrije Univ Brussel, Biol Testis BITE, B-1090 Brussels, Belgium
[2] Univ Ziekenhuis Brussel, Centrum Reprod Geneeskunde, B-1090 Brussels, Belgium
来源
GYNECOLOGIE OBSTETRIQUE & FERTILITE | 2013年 / 41卷 / 09期
关键词
Spermatogonial stem cell; Testicular tissue; Transplantation; CLINICAL-APPLICATION; SPERMATOGENESIS; TISSUE; SPERM; TESTIS; SURVIVAL; PROGENY; CANCER; MICE;
D O I
10.1016/j.gyobfe.2013.07.013
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Spermatogonial stem cells (SSC) are the founder cells of spermatogenesis and are responsible for the lifelong production of spermatozoa. The cryopreservation and transplantation of these cells has been proposed as a fertility preservation strategy for young boys at risk for stem cell loss, i.e. patients undergoing chemotherapy for cancer or as a conditioning treatment for bone marrow transplantation. To prevent lifelong sterility in boys, two fertility restoration strategies are being developed: the injection of SSC and the grafting of testicular tissue containing SSC. Depending on the disease of the patient one of these two approaches will be applicable. Grafting has the advantage that SSC can reside within their natural niche, preserving the interactions between germ cells and their supporting cells and may therefore be regarded as the first choice strategy. However, in cases where the risk for malignant contamination of the testicular tissue is real, e.g. leukemia, transplantation of SSC by injection is preferable over grafting. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:529 / 531
页数:3
相关论文
共 50 条